Recent changes

Favicon for recalls-rappels.canada.ca

Salt of the Earth Cream Recalled Due to Chemical Hazard

Health Canada has issued a consumer product recall for Salt of the Earth Cedar and Amyris Replenish Cream due to a chemical hazard. The product contains methyl eugenol above the maximum concentration allowed by the Cosmetic Ingredient Hotlist. Consumers are advised to stop using the product immediately.

Urgent Notice Product Safety
Favicon for recalls-rappels.canada.ca

ICIM Halloumi Cheese Recalled Due to Undeclared Milk

The Canadian Food Inspection Agency has issued a recall for ICIM brand Halloumi Cheese due to undeclared sheep milk and goat milk. Consumers are advised not to use, sell, serve, or distribute the affected product.

Urgent Notice Food Safety
Favicon for recalls-rappels.canada.ca

ZoRaw Milk Chocolate Recalled for Undeclared Almond and Peanut

The Canadian Food Inspection Agency has issued a recall for ZoRaw brand Milk Chocolate products due to undeclared almond and peanut allergens. Consumers are advised not to consume the affected products.

Urgent Notice Food Safety
Favicon for recalls-rappels.canada.ca

Health Canada Recall: Cream Chargers Sold for Inhalation Without Market Authorization

Health Canada has issued a recall for various brands of cream chargers sold for inhalation without market authorization. Consumers are warned not to inhale nitrous oxide products recreationally and to seek medical attention if experiencing side effects. Retailers and wholesalers are involved in the recall.

Urgent Notice Product Safety
Favicon for recalls-rappels.canada.ca

Cool Fidget Toy Stress Ball Recalled for Ingestion Hazard

Health Canada has recalled the "Cool Fidget Toy Stress Ball" due to an ingestion hazard posed by small, powerful magnets. The product fails to meet safety performance criteria under the Canada Consumer Product Safety Act. Consumers are instructed to stop using and dispose of the product.

Urgent Enforcement Product Safety
11d ago CRTC Releases
Favicon for crtc.gc.ca

Telecom Consultation on CCTS Fee Structure

The Canadian Radio-television and Telecommunications Commission (CRTC) has extended deadlines for a consultation on the fee structure and dispute mechanism of the Commission for Complaints for Telecom-television Services Inc. (CCTS). The revised deadlines for submissions are April 7, 2026, for CCTS responses, April 21, 2026, for interventions, and May 26, 2026, for replies.

Priority review Consultation Telecommunications
11d ago CRTC Releases
Favicon for crtc.gc.ca

Bell Canada Withdraws Features of Small Business Service

The Canadian Radio-television and Telecommunications Commission (CRTC) has approved Bell Canada's application to withdraw certain features of its Bell Total Connect for Small Business service. The affected features include Soft Client, Mobile Application, and Call Dashboard, due to end-of-life equipment. The withdrawal is effective September 30, 2025.

Routine Rule Telecommunications
11d ago CRTC Releases
Favicon for crtc.gc.ca

CRTC Policy Prohibits Fees Barrier to Switching Cellphone and Internet Plans

The CRTC has issued a new policy prohibiting fees that act as a barrier for consumers switching cellphone and Internet plans. These changes, effective June 12, 2026, amend the Wireless Code and Internet Code to empower consumers and align with recent amendments to the Telecommunications Act.

Priority review Rule Telecommunications
Favicon for www.canada.ca

Teva Octreotide Recalled Due to Manufacturing Deficiencies

Health Canada has issued a Type I drug recall for Teva Octreotide due to manufacturing site deficiencies identified at a foreign facility. These deficiencies could lead to potential quality issues, including compromised sterility and dosing accuracy. The recall is a precautionary measure.

Urgent Enforcement Pharmaceuticals
Favicon for www.canada.ca

Health Canada Health Product InfoWatch - February 2026

Health Canada's February 2026 Health Product InfoWatch includes a monthly recap of safety information, including a recall of Teva Octreotide and advisories on unauthorized products. It also announces a consultation on controlling zuranolone and new market authorizations with conditions.

Priority review Notice Pharmaceuticals

Showing 131–140 of 221 changes

1 12 13 14 15 16 23

Get Canada alerts

Daily digest of regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.